Pennsaid

Pennsaid is a brand name of diclofenac topical, approved by the FDA in the following formulation(s):

PENNSAID (diclofenac sodium - solution; topical)

• 
  Manufacturer: MALLINCKRODT
  
  Approval date: November 4, 2009
  
  Strength(s): 1.5% ^[RLD]

Has a generic version of Pennsaid been approved?

No. There is currently no therapeutically equivalent version of Pennsaid available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Pennsaid. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Pennsaid.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • November 4, 2012 - NEW DOSAGE FORM
  
  

See also...

• Pennsaid Consumer Information (Drugs.com)
• Pennsaid Solution Consumer Information (Wolters Kluwer)
• Pennsaid Consumer Information (Cerner Multum)
• Pennsaid Topical Advanced Consumer Information (Micromedex)
• Diclofenac Gel Consumer Information (Wolters Kluwer)
• Diclofenac Patch Consumer Information (Wolters Kluwer)
• Diclofenac Solution Consumer Information (Wolters Kluwer)
• Diclofenac topical Consumer Information (Cerner Multum)
• Diclofenac transdermal Consumer Information (Cerner Multum)
• Voltaren Topical Advanced Consumer Information (Micromedex)
• Diclofenac Topical Advanced Consumer Information (Micromedex)
• Diclofenac Sodium topical AHFS DI Monographs (ASHP)